Sprint Bioscience AB (publ) (SPRINT.ST)

SEK 1.6

(0.25%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 50.48 Million 83 Thousand 35.11 Million 16.88 Million 33.54 Million 17.93 Million
Cost of Revenue 8.69 Million 60.99 Million 10.43 Million 10.45 Million 8.17 Million 745 Thousand
Gross Profit 41.78 Million -60.9 Million 24.67 Million 6.42 Million 25.36 Million 17.19 Million
Operating Expenses 42.63 Million 47.32 Million 50.14 Million 44.1 Million 45.78 Million 39.27 Million
Selling, General and Administrative Expenses 42.63 Million 47.44 Million 22.17 Million 21.1 Million 18.28 Million 17.21 Million
Research and Development Expenses - - - - - -
Other Expenses - - 27.96 Million 22.99 Million 27.5 Million 22.06 Million
Cost and Expenses 51.33 Million 60.99 Million 60.58 Million 54.56 Million 53.96 Million 40.02 Million
Operating Income -845 Thousand -60.9 Million -25.46 Million -37.67 Million -20.42 Million -22.05 Million
Interest Expense - - 269 Thousand 3.44 Million 1.2 Million 137 Thousand
Income Tax Expense - - 269 Thousand 3.44 Million 1.2 Million 7000.00
Earnings before Tax -438 Thousand -60.17 Million -25.08 Million -42.79 Million -21.53 Million -22.21 Million
Net Income -438 Thousand -60.17 Million -25.35 Million -46.23 Million -22.74 Million -22.21 Million
Earnings Per Share Basic -0.01 -1.43 -0.73 -2.23 -1.51 -1.88
Earnings Per Share Diluted -0.01 -1.43 -0.73 -2.23 -1.51 -1.88
Weighted Average Shares Outstanding 69.8 Million 42.05 Million 34.65 Million 20.69 Million 15.04 Million 11.84 Million
Weighted Average Shares Outstanding (Diluted) 69.8 Million 42.05 Million 34.65 Million 20.69 Million 15.04 Million 11.84 Million
Gross Margin 0.83 -733.84 0.70 0.38 0.76 0.96
EBIT Margin -0.04 -726.40 -0.69 -2.29 -0.58 -1.19
Profit Margin -0.01 -724.94 -0.72 -2.74 -0.68 -1.24
EBITDA -2.08 Million -59.99 Million -24.49 Million -38.05 Million -19.58 Million -31.06 Million
Earnings Before Tax Margin -0.02 -733.84 -0.73 -2.23 -0.61 -1.23

Income Statement Charts